Hemophilus influenzae type B susceptibility to 17 antibiotics.

PubWeight™: 2.74‹?› | Rank: Top 1%

🔗 View Article (PMID 1079251)

Published in J Pediatr on April 01, 1975

Authors

B B Emerson, A L Smith, A L Harding, D H Smith

Articles citing this

Comparison of in vitro activity of cephalexin, cephradine, and cefaclor. Antimicrob Agents Chemother (1977) 7.14

In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87

Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60

In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains. Antimicrob Agents Chemother (1977) 1.36

Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species. Antimicrob Agents Chemother (1980) 1.31

Limited in vitro activity of cefamandole against 100 beta-lactamase- and non-beta-lactamase-producing Haemophilus influenzae strains: comparison of moxalactam, chloramphenicol, and ampicillin. Antimicrob Agents Chemother (1981) 1.20

Method for evaluating broth culture media: application to Haemophilus. J Clin Microbiol (1978) 1.20

Comparative acitivity of ampicillin and cefuroxime against three types of Haemophilus influenzae. Antimicrob Agents Chemother (1977) 1.19

Effect of ampicillin and chloramphenicol alone and in combination on ampicillin-susceptible and -resistant Haemophilus influenzae type B. Antimicrob Agents Chemother (1979) 1.15

Penetration of cefazolin into pleural fluid. Antimicrob Agents Chemother (1977) 1.09

Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae. Antimicrob Agents Chemother (1981) 1.04

In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother (1978) 1.02

Characterization of ampicillin-resistant Haemophilus parainfluenzae. Antimicrob Agents Chemother (1982) 1.02

Manner and meaning of susceptibility testing of ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1977) 0.99

Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole. Antimicrob Agents Chemother (1978) 0.83

Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 0.79

Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature. Tex Heart Inst J (1986) 0.75

Articles by these authors

In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol (1988) 12.52

Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (1985) 12.08

Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol (1999) 11.77

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell (1987) 11.56

Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell (1987) 11.15

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98

Human serum activities against Hemophilus influenzae, type b. J Clin Invest (1972) 7.85

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67

A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23

Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene. Nature (1983) 5.90

Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun (1980) 5.68

Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J Clin Microbiol (1998) 5.27

Transferable R factors in enteric bacteria causing infection of the genitourinary tract. Lancet (1966) 5.01

Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93

Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80

R factors mediate resistance to mercury, nickel, and cobalt. Science (1967) 4.57

Expression of active human factor VIII from recombinant DNA clones. Nature (1984) 4.36

Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12

Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. Nature (1983) 4.06

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03

Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1984) 3.98

Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82

Marburg-virus disease in Kenya. Lancet (1982) 3.79

A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator. Mol Cell Biol (1988) 3.74

Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics (1973) 3.33

Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31

Primary structure and biochemical properties of an M2 muscarinic receptor. Science (1987) 3.16

Mode of action of novobiocin in Escherichia coli. J Bacteriol (1967) 3.09

Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05

The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicol Appl Pharmacol (1969) 2.95

Identification of coryneform bacterial isolates by ribosomal DNA sequence analysis. J Clin Microbiol (2000) 2.87

Do pili play a role in pathogenicity of Haemophilus influenzae type B? Lancet (1982) 2.84

Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest (1972) 2.81

Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71

Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29. Proc Natl Acad Sci U S A (1983) 2.66

Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48

Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45

The costs of treating COPD in the United States. Chest (2001) 2.43

Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens. J Clin Invest (1980) 2.42

Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci (1992) 2.41

Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41

Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J (1987) 2.39

Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38

L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36

Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus infleunzae type b. J Pediatr (1972) 2.33

Role of heat-labile toxigenic Escherichia coli and Reovirus-like agent in diarrhoea in Boston children. Lancet (1975) 2.31

Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30

Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28

Studies on the epidemiology of resistance (R) factors. I. Analysis of Klebsiella isolates in a general hospital. II. A prospective study of R factor transfer in the host. Ann Intern Med (1969) 2.28

Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci (2001) 2.28

Recovery of resistance (R) factors from a drug-free community. Lancet (1969) 2.26

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci U S A (1991) 2.24

Isolation and partial characterization of outer and inner membranes from encapsulated Haemophilus influenzae type b. J Bacteriol (1981) 2.21

The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics (1989) 2.17

The reliability of quantitative electroencephalography as an indicator of cerebral ischemia. Anesth Analg (1995) 2.12

Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11

Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07

The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess (2006) 2.04

Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04

Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03

Comparison of protein A gene sequencing with pulsed-field gel electrophoresis and epidemiologic data for molecular typing of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2000) 2.03

The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01

Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00

Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00

A health week in rural general practice. Br Med J (1967) 1.99

Measuring appropriate use of acute beds. A systematic review of methods and results. Health Policy (2000) 1.97

An inhibitor of indoleacetic acid oxidase from pea tips. Plant Physiol (1961) 1.97

Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95

The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94

Sepsis and congenital asplenia. J Pediatr (1977) 1.93

T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92

In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87

Who should practise? Where? CMAJ (1994) 1.87

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84

Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84

A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84

Human antibody response to individual outer membrane proteins of Haemophilus influenzae type b. Infect Immun (1982) 1.83

Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79

Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79

Resistance factor-mediated streptomycin resistance. J Bacteriol (1969) 1.78

The MHC-binding and gp120-binding functions of CD4 are separable. Science (1989) 1.77

Characterization of R factor beta-lactamases by the acidimetric method. Antimicrob Agents Chemother (1973) 1.76

Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Proc Natl Acad Sci U S A (1991) 1.76

Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol (1982) 1.74

Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74